Importance Ultrasonography-based risk models can help nonexpert clinicians evaluate
adnexal lesions and reduce surgical interventions for benign tumors. Yet, these models …

Despite advances in medicine, ovarian cancer remains the deadliest of the gynecological
malignancies. Herein we present the latest information on the pathophysiology of ovarian …

Objective The aim was to systematically review the characteristics of ovarian cancer in
women with Lynch syndrome (LS) and evaluate the role of surveillance in detection of …

Ovarian cancer is the most lethal of malignant gynecological tumors. Its lethality may be due
to difficulties in detecting it at an early stage and lack of effective treatments for patients with …

Ovarian carcinoma is the most lethal gynaecologic malignancy. Despite wide initial
sensibility to chemotherapy especially to platinum-based regimens, the vast majority of …

Background: Several popular screening tests, such as mammography and prostate-specific
antigen, have met with wide controversy and/or have lost their endorsement recently. We …

Ovarian cancer carries a lifetime risk of approximately 2% for women and is the leading
cause of death from any gynecologic malignancy. Currently, no screening program for …

Background Only about half the studies that have collected information on the relevance of
women's height and body mass index to their risk of developing ovarian cancer have …

There are several definitions of biomarkers. A biomarker is a characteristic that can be
objectively measured and evaluated as an indicator of a physiological as well as a …

Adnexal masses can have gynecologic or nongynecologic etiologies, ranging from normal
luteal cysts to ovarian cancer to bowel abscesses. Women who report abdominal or pelvic …